21.55 +0.01 (0.05%)
After hours: 6:23PM EST
Previous Close | 21.69 |
Open | 21.48 |
Bid | 20.03 x 1200 |
Ask | 21.55 x 900 |
Day's Range | 20.84 - 22.09 |
52 Week Range | 11.98 - 23.02 |
Volume | 1,457,184 |
Avg. Volume | 1,298,004 |
Market Cap | 3.428B |
Beta (5Y Monthly) | 1.25 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.46 |
Earnings Date | Feb 10, 2021 - Feb 15, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 21.36 |
BioCryst (BCRX) gets approval in Japan for oral, once-daily Orladeyo 150 mg for prophylactic treatment of hereditary angioedema (HAE) in adults and pediatric patients 12 years or older.
Ultragenyx's (RARE) IND application for UX701 for the treatment of Wilson Disease gets FDA clearance.
Bristol Myers' (BMY) sBLA for the label expansion of Opdivo for gastric cancer, gastroesophageal junction cancer or esophageal adenocarcinoma gets priority review.